Workflow
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) came out with a quarterly loss of 1.78pershareversustheZacksConsensusEstimateofalossof1.78 per share versus the Zacks Consensus Estimate of a loss of 1.93. This compares to earnings of 4.2pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+7.774.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.77%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of 1.74 per share when it actually produced a loss of $1.93, delivering a surprise of -10.92%.Over the last four quarte ...